Zydus Cadila has received the final approval from the USFDA to market Albendazole Tablets USP (US RLD ALBENZA tablets), 200 mg. It will be manufactured at the group's formulations manufacturing facility at SEZ, Ahmedabad. This medication is used to treat certain tapeworm infections (such as neurocysticercosis and hydatid disease).
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
